Clinical Trials Logo
  1. Home
  2. Other
  3. NCT01741831

A Post Marketing Survey Study to Evaluate the Safety and Effectiveness of Prezista

Acquired Immune Deficiency Syndrome Clinical Trial

Official title:
Regulatory Post Marketing Surveillance of Prezista 400mg Tablet

Clinical Trial Summary

The purpose of this study is to assess the safety data of darunavir in a natural clinical practice.

Clinical Trial Description

This is a non-interventional (a scientific study to make a clear and easy understanding of the cause and effect relationship), prospective (in which the participants are first identified and then followed forward as time passes), consecutive survey for collecting safety and efficacy data of darunavir in treatment of Acquired Immune Deficiency Syndrome (AIDS) in a natural clinical practice. ;

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01741831
Study type Observational
Source Janssen Korea, Ltd., Korea
Contact
Status Completed
Phase Phase 4
Start date July 2012
Completion date October 2016
View Details
See also
  Status Clinical Trial Phase
Completed NCT01741844 - A Post Marketing Survey Study to Evaluate the Safety and Effectiveness of Intelence Phase 4
Terminated NCT00637962 - Reactogenicity and Immunogenicity of Vaginal CNgp140 Phase 1
Terminated NCT00775606 - Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in Advanced HIV Disease Phase 4
Enrolling by invitation NCT00758212 - Influenza Vaccination at a Reduced Dose Using Mesotherapy in HIV/AIDS Patients at the Hadassah AIDS Center, Jerusalem N/A
Completed NCT00814879 - Pilot Study of a Raltegravir Based NRTI Sparing Regimen N/A
Not yet recruiting NCT00872417 - Study on the Antiviral Therapy and Immune Reconstitution of Chinese HIV/AIDS Patients Phase 4
Recruiting NCT05398185 - WiseApp for Spanish Speakers Living With HIV N/A
Completed NCT02670772 - Dose Optimisation of Stavudine for the Treatment of HIV Infection Phase 3
Completed NCT00972699 - Mentor Mothers: A Sustainable Family Intervention in South African Townships Phase 2
Withdrawn NCT01173510 - A Pilot Study to Determine if Raltegravir Eradicates HIV From Peripheral Blood Mononuclear Cells Phase 4
Active, not recruiting NCT00499434 - Correlation Between Cytokines and Hepatic Histology in Patients Infected by HIV-1 and the Hepatitis-C Virus N/A
Completed NCT00055185 - Safety and Efficacy of PRO 542 in the Treatment of HIV-Infected Patients Phase 2